Pure Global AI
ANVISA registration 80105220317Active

ANTIBODY FOR CELIAC DISEASE

ANVISA Registration Number: 80105220317KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDADIYALAB ZJG BIOTECH CO., LTDRisk Class II
Verified
Device names
Technical name
ANTIBODY FOR CELIAC DISEASE
View exact technical-name matches →
PT: ANTICORPO PARA DOENÇA CELÍACA
Commercial name
Anti-tissue Transglutaminase Antibody IgA /IgG Assay Kit (Fluorescence Immunoassay)
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
80105220317
Process Number
25351119359202648
CNPJ
04299232000143
Company information
Registration Holder
KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA
Manufacturer
DIYALAB ZJG BIOTECH CO., LTD
Manufacturing Country
China
PT: CHINA, REPÚBLICA POPULAR
Dates and status
Publication Date
Jul 27, 2026
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTIBODY FOR CELIAC DISEASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80105220317 and manufactured by DIYALAB ZJG BIOTECH CO., LTD. The registration is held by KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.